Akebia Therapeutics (AKBA)
NASDAQ:AKBA

Akebia Therapeutics (AKBA) Similar Stocks

1,242 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Akebia Therapeutics
$310.20M
-6.69
2.07%
2 Buy
0 Hold
0 Sell
Moderate Buy
$4.50
BioMarin Pharmaceutical
$16.25B
80.10
-1.93%
9 Buy
4 Hold
0 Sell
Moderate Buy
$105.08
Gilead Sciences
$95.32B
213.30
3.29%
11 Buy
10 Hold
0 Sell
Moderate Buy
$81.26
Incyte
$15.42B
20.81
9.19%
4 Buy
5 Hold
1 Sell
Moderate Buy
$65.63
Karyopharm Therapeutics
$119.67M
-0.75
-44.51%
4 Buy
1 Hold
0 Sell
Strong Buy
$5.00

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
AKBA
Akebia Therapeutics
1.48
-0.04
-2.63%
BMRN
BioMarin Pharmaceutical
85.59
-0.97
-1.12%
GILD
Gilead Sciences
76.51
3.09
4.21%
INCY
Incyte
68.57
5.89
9.40%
KPTI
Karyopharm Therapeutics
0.96
-0.73
-43.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis